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1. Introduction 
The nosological definition of inflammatory pancreatic diseases appears rather difficult and 
uncertain, as proved by the great number of classifications which have been proposed in the 
last few decades, showing that the definition and classification of this disease is still under 
critical review. The reason is the reduced availability or, in the majority of the cases, the 
absence of histological findings which can be connected to a clinical picture that moreover is 
often subject to evolutions. A not negligible role in generating uncertainties is played by the 
very diversified territorial distribution of the various forms of pancreatitis: this provides to 
the different observers different and often hardly reconcilable experiences. Therefore, the 
succeeding classifications are based exclusively on clinical or laboratory data or on imaging 
exams. We can consider as stable references the basic anatomo-clinical correspondences. It is 
preliminarily acquired that the parenchymal phlogistic process recognizes its origin in the 
self-digestive effect of the same pancreatic proteolytic enzymes. Self-limiting parenchymal 
inflammation characterizes mild and moderate acute pancreatitis. Self-digestive processes of 
serious entity with parenchymal necrosis and peripancreatic fluid collections manifest 
themselves as severe acute pancreatitis (SAP). Finally, chronic pancreatitis is histologically 
characterized by fibrosis, sclerosis and calcifications. Historically, the rigorous and well-
defined distinction between acute and chronic pancreatitis has represented for a long time 
the basis of classifications in which acute and chronic pancreatitis were substantially 
considered two different diseases but, in the course of time, important modifications have 
taken place. In fact, currently this distinction is in discussion due to the imaging of the main 
bile duct and of the duct of Wirsung and above all due to the more comprehensive, 
prolonged and detailed clinical observations which allow to estimate the sometimes long 
evolution of pancreatitis. These observations show that acute and chronic forms overlap 
(Bassi & Butturini , 2007). The onset and/or the acute manifestations of chronic pancreatitis 
are considered and also the acute pancreatitis which, because of the repeated acute episodes, 
evolve anatomo-clinically towards chronicity. Recurrent acute pancreatitis is characterized 
by several acute episodes which follow the first attack. On the whole, the risk of recurrence 
for pancreatitis with different etiology is contained (20-30%). On the contrary the patients 
who present a second attack have a much higher risk of further recurrences and therefore 
require a rigorous diagnostic investigation. Biliary lithiasis and excessive alcohol 
consumption are the more frequent causes of pancreatitis, reaching as a whole the total 
incidence of 80% (Barthet, 2001; Gullo et al, 2002). However, the frequency rate between 
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biliary and alcoholic etiology is subject to great variations in relation to geographic 
distribution. Moreover, even if with much contained frequency, numerous other causes of 
pancreatitis are recognized which may manifest as recurrent and which, on the whole, 
represent 20% of the total (Ferec & Maire, 2005; Hastier, 2005) : hereditary, metabolic 
pancreatitis (hyperlipidemia, hypercalcaemia, steroids), from neoplastic ductal obstruction 
(intraductal papillary mucinous neoplasms (IPMN), periampullary tumors,etc), from 
congenital anomalies (pancreas divisum, annular pancreas, anomalies of the biliopancreatic 
junction), from dysfunction of the sphincter of Oddi, from drugs and toxic substances, 
trauma and infections and finally post-endoscopic retrograde cholangiopancreatography 
(ERCP) pancreatitis. Among all the various forms of recurrent pancreatitis, the conditions 
based on the obstruction of the flow of pancreatic secretions amenable to endoscopic 
treatment (ERCP-Endoscopic Sphincterotomy (ES)) are in evidence: biliary pancreatitis, 
dysfunction of the sphincter of Oddi, pancreas divisum. The object of our interest is the 
anatomo-clinical condition of recurrent pancreatitis. Pancreatic inflammatory diseases may 
evolve towards chronicity because of either the episodic increase of the phlogistic response 
and/or the recurrence of acute attacks. In pancreatitis with different etiopathogenesis it is 
useful to examine which are the possible different pathogenetic modalities of pancreatitis 
recurrence and its possible evolution. On the basis of the clinical presentation, acute 
pancreatitis, in particular those of biliary etiology, can be subdivided in mild, moderate and 
severe: the former, which include clinical forms of different relevance and extension, 
represent the majority of acute pancreatitis (75%). Severe forms constitute the remaining 
25%. Among these an ulterior 20% is represented by forms of particular and sudden severity 
(early severe acute pancreatitis (ESAP)) (Beger & Rau , 2007). Pancreatitis incidence increases 
stably with the increase of the average age of population and with the increased incidence of 
biliary lithiasis and alcohol consumption. Unlike in chronic pancreatitis in which fibrosis 
does not revert and there is no total recovery with restoration of the original condition, 
patients with an attack of acute pancreatitis, particularly in mild/moderate forms, show an 
almost complete anatomical and functional recovery. However, there remains still the 
possibility of other recurrent attacks. The reason of this possible evolution can be recognized 
in at least two circumstances: either the initial and effective cause persists or it is not 
completely removed by the therapeutic intervention: biliary lithiasis or biliary sludge, 
cholelithiasis, inflammatory papillary stenosis, invariated alcohol consumption, tumors 
obstructing the main pancreatic duct. Also severe pancreatitis with extended necrotic 
parenchymal areas can evolve into chronic pancreatitis for successive stenosis of the main 
pancreatic duct. The possibility of the evolution of an acute inflammatory process into a 
chronic phlogistic condition returns therefore in evidence. The distinction between acute 
and chronic pancreatitis is based on the natural history, the characteristics of the clinical 
picture and the anatomo-pathological alterations. Acute pancreatitis starts out in patients 
with no history of related illness and with the possibility of a complete resolution especially 
in mild/moderate forms. On the contrary, the anatomical and functional recovery in severe 
forms can be compromised. Moreover in SAP with severe impairment of the general clinical 
conditions and important structural alterations, the prognosis is serious. In chronic 
pancreatitis the organ impairment and the persistence of painful symptomatology of 
moderate severity characterize the intervals between the acute attacks. However, the acute 
attack, both in acute and chronic pancreatitis, is characterized by acute onset and by very 
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similar symptoms. Therefore, in the absence of an histological exam and of prolonged 
observation, the distinction between the two forms may be difficult. Regarding this point, 
SAP and ESAP often with biliary etiopathogenesis and with impairment of clinical 
conditions, must be considered with attention. In fact, the acute onset in chronic pancreatitis 
and severe acute pancreatitis may be distinguished for the presence in the latter of a severe 
impairment of clinical conditions which impairs the prognosis. All these considerations 
contribute to establish a connection between acute and chronic forms. The inflammatory 
process underlying acute pancreatitis can resolve if the recurrence of acute episodes is 
interrupted in the early stages. But, if the conditions which determine the recurrence of the 
acute attacks persist, like for example papillary sclerosis or obstruction with reflux in the 
duct of Wirsung, then inflammation will be able to evolve into fibrosis and acute 
pancreatitis will evolve anatomically and clinically into chronic pancreatitis. Therefore, 
recurrent pancreatitis may be considered the clinical condition which constitutes the bridge 
between acute and chronic pancreatitis. In fact, pancreatic inflammation may show a chronic 
evolution through the recurrence of acute episodes. Thus it is important to establish through 
which anatomical alterations and how in the pancreatitis of various etiologies this evolution 
is determined. 
2. Biliary pancreatitis 
Pathogenetic modalities of recurrent pancreatitis are well evident in biliary pancreatitis. 
Recurrent acute biliary pancreatitis is caused by obstacle in the papillary patency with 
abnormal biliopancreatic flow. Papillary obstacle, caused by gallstones, biliary sludge, 
cholesterol cristals, sclerosis or edema, determines biliopancreatic reflux in the pancreatic 
duct with consequent pancreatitis. Therefore, restoring the normal transpapillary flow and 
cleaning the common bile duct (CBD) can prevent pancreatitis recurrences. This 
pathogenetic pattern of acute biliary pancreatitis (ABP) is by now widely documented 
(Frossard et al.,2008; Lee et al, 1992; Opie, 1901; Pandol SJ, 2006; Wang et al, 2009). The 
incidence of recurrent biliary pancreatitis is reported to widely vary between 30% and 60% 
in patients who did not undergo cholecystectomy and ES, often with a short interval 
between the first and the second attack: 4-6 weeks (Heider et al, 2006; Van Geenen et al, 
2009). Our purpose is to evaluate the possibility and the means to prevent recurrent acute 
biliary pancreatitis. Detailed examination of an homogeneous series contributes to clarify 
the anatomo-clinical details. The study evaluated the patients with ABP admitted to our 
hospital in the period September 1997 - December 2010. We collected a total of 261 cases, 
mean age 49 (20-86), M 112 – F 149, including 203 (77,7%) mild/moderate and 58 (22,3%) 
severe pancreatitis (Tab 1). Among moderate pancreatitis, we recognized 31 (15,7%) 
moderate/severe pancreatitis, characterized by extensive pancreatic and peripancreatic 
inflammation with fluid collections and mild necrosis, without however impairment of the 
general clinical conditions (Heider et al, 2006; Nealon et al, 2004). We selected, through the 
medical records, the patients who had a first attack of ABP, distinguishing them from the 
ones who had previously suffered from one or more episodes of ABP. The patients with a 
first attack of onset were on the whole 188 (72,3%), while those with previous repeated 
episodes were 73 (28%). Among the 73 recurrent pancreatitis, 12 (16,4%) were severe and 61 
(83,6%) moderate/mild (Tab. 2). 
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MEAN 
AGE 
SEX Dir. 
BIL. 
< 2 
mg/dl
Dir. 
Bil. 
2-5 
mg/dl
AST/ALT 
x3 iU/l 
gamma-
GT 
>200 
iU/l 
ALP 
>150 
iU/l 
CBD 
size 
(US)> 8 
mm 
Cholecystic 
Lithiasis 
49 
(20-86) 
F 149 
M 112
60.4% 39.6% 
 
26.8% 59.9% 53.6% 40.7% 100% 
EDEMATOUS 187 71.64% 
NECROTIZING 74 28.36% 
PERIPANCREATIC FLUID 
COLLECTION 
95/261 36.39% 
Table 1. Demographic data, percentage incidence of biliary lithiasis and cholestasis tests, 
pancreatitis morphology (US/CT) in 261 acute biliary pancreatitis at the admission in our 
Hospital. 
 
MEAN 
AGE 
SEX Dir. 
Bil. 
< 2 
mg/dl
Dir. 
Bil. 
2-5 
mg/dl
AST/ALT
x3 iU/l 
gamma-
GT 
>200 
iU/l 
ALP 
>150 
iU/l 
CBD size 
(US)>8mm 
Cholecystic 
Lithiasis 
54 
(28-76) 
F 44 
M 29 
47.2% 52.8%
 
31.2% 64.3% 59.4% 48.2% 100% 
EDEMATOUS 54 73.97% 
NECROTIZING 19 26.03% 
PERIPANCREATIC 
FLUID 
COLLECTION 
33/73 45.20% 
Table 2. Demographic data, percentage incidence of biliary lithiasis and cholestasis tests, 
pancreatitis morphology (US/CT) in 73 recurrent acute pancreatitis at the admission in our 
Hospital. 
The acute episode of pancreatitis was defined by the presence of abdominal epi-mesogastric 
pain radiating through to the back and by increased serum amylase and lipase levels. To 
establish the gallstone etiology of pancreatitis, we searched, in all patients, on 
ultrasonography, gallbladder lithiasis and/or gallstones, sludge, microlithiasis etc. in the 
CBD or also a dilatation of the CBD (>8 mm). Laboratory cholestasis tests were on average 
positive in 40% of patients: direct bilirubin between 2 and 5 mg/l, alkaline phosphatase 
>150 U/l and gamma-GT >200 U/l. Alcohol consumption in these patients had also been 
excluded. The severity of pancreatic involvement was assessed with abdominal ultrasound 
(US) at the admission and with computed tomography (CT) (Balthazar criteria)(Balthazar et 
al, 1990) after 48-72-hours. The patients with previous attacks of recurrent acute pancreatitis 
have not been submitted, during the previous hospitalizations, to any specific therapy for 
pancreatitis (ERCP/ES, cholecystectomy), but only to simple supportive therapy. In this 
group, with recurrent pancreatitis, control of gallstone etiology, laboratory cholestasis tests 
and the CT pancreatic involvement were not dissimilar compared to all patients. All patients 
underwent the complete treatment for ABP, adjusted according to the degree of severity of 
the disease: intensive therapy, clinical and instrumental monitoring of papillary patency, 
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ERCP/ES (209/261=80%) within 72 hours from the onset in all severe pancreatitis (58) (in 3 
cases this procedure was unsuccessful and in 7 cases it was delayed for 10 days), in all 
recurrent pancreatitis (73), in all moderate/severe pancreatitis (31) with extensive 
inflammatory pancreatic and peripancreatic involvement, fluid collection and mild 
pancreatic necrosis (as shown by CT), but without organ failure and finally in 
moderate/mild pancreatitis with laboratory cholestasis tests and instrumental (US/MRCP) 
confirmation of papillary obstacle (lithiasis, microlithiasis, sludge in CBD, papillary edema, 
stenosis, etc.) (59/203, 29%). The treatment was completed with laparoscopic 
cholecystectomy: 254 video-laparocholecystectomies (VLC) and 7 open cholecystectomies. 
The timing of cholecystectomy varied according to the severity of pancreatitis; generally, we 
waited for the stabilization of the pancreatic and peripancreatic phlogosis/necrosis and of 
the patient’s clinical conditions. After the treatment and the discharge, all the patients were 
introduced in a follow-up program (clinical and instrumental control after 90 and 180 days). 
The 73 patients with recurrent pancreatitis, after the standard therapeutic program and the 
discharge, entered a follow-up program with clinical and instrumental controls at 90 and 
180 days. Forty-two (57,5%) patients were monitored (31 patients could not be reached): the 
results of the follow-up showed, beside the absence of critical episodes, the stable 
normalization of laboratory and instrumental cholestasis tests at the first (90 days) and at 
the second control (180 days) (Tab 3). A further recurrence has occurred only in 2 patients 
(2/42 = 2,7%) with a moderate/mild pancreatitis at the 145th day from the discharge. Once 
the persistence of the papillary obstacle for incomplete sphincterotomy had been assessed, 
the resolution was obtained with medical therapy and a new ES. 
 
Tot. Bil. 
 
ALP 
 
AST/ALT 
 
Amylase
 
Lipase 
 
gamma-
GT 
 
CBD 
size 
(US) 
Recurrence 
0.80 
mg/dl 
115 
iU/l 
24/50 
iU/l 
220  
iU/l 
110 
iU/l 
38 
iU/l 
6 
mm 
2 (2.7%) 
Table 3. Recurrent acute biliary pancreatitis 42/73 (57.5%) : follow-up (180 days)  
Cholestasis tests were on average normal. 
The same controls in 88 patients (88/188 = 46,8%) with a first attack of acute pancreatitis, at 
90 and 180 days from the discharge resulted normal, in the absence of new acute episodes 
(Tab 4).  
 
Tot. Bil. 
 
ALP 
 
AST/ALT 
 
Amylase 
 
Lipase 
 
gamma-
GT 
 
CBD 
size 
(US) 
Recurrence 
0.90 
mg/dl 
112 
iU/l 
28/40 
iU/l 
95 
iU/l 
158 
iU/l 
54 
iU/l 
5 
mm 
_ 
Table 4. Acute biliary pancreatitis 88/188 (46,4%) : follow-up (180 days)  
Cholestasis tests were on average normal. 
We believe that ES has a control role in the therapy of ABP. Biliary pancreatitis presents 
clinical findings of different severity. Signs and symptoms of reference, always present, 
consist in epigastric pain with acute onset and characteristic radiation to the back and 
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evident increase of serum amylase and lipase levels. Moderate/mild pancreatitis, with 
pancreatic or peripancreatic edema, is not accompanied by impairment of the patient’s 
general clinical conditions, requires only supportive therapy and generally evolves towards 
a spontaneous recovery. In these patients cholecystectomy is indicated and is performed, as 
a general rule, while the patient is still hospitalized. In moderate/mild pancreatitis ES is not 
generally indicated because the papillary obstacle is transient and probably incomplete. In 
the cases showing clinical and laboratory signs or ultrasound evidence of cholestasis, 
instrumental control of the bile duct with magnetic resonance cholangiopancreatography 
(MRCP) is proposed. ERCP/ES is used as therapy only in case of lithiasic obstacles or biliary 
sludge in the CBD or papillary stenosis. Moreover the advisability of an instrumental 
control of the bile duct with MRCP is discussed in patients with mild acute pancreatitis who 
do not show any clinical or instrumental sign of cholestasis, as an additional exam beside 
the routine abdominal ultrasonography before cholecystectomy. The incidence of gallstones 
in the population of western countries is about 15% and among these patients about 10-15% 
have choledocholithiasis (Tazuma, 2006). The literature data show that a very variable range 
(45-75%) of patients with acute biliary pancreatitis has stones in the CBD (Barro et al,2005; 
Young et al,2003). The cases with acute biliary pancreatitis include mild/moderate self-
limiting forms with transient papillary obstacle, which are not accompanied by clinical, 
laboratory or instrumental signs of cholestasis. For these mild/moderate forms of acute 
pancreatitis the use of invasive procedures to explore the CBD is not advisable, while it is 
necessary to demonstrate the absence of stones in the CBD. For these reasons in patients 
with mild/moderate acute biliary pancreatitis without increase of cholestasis indexes and in 
the absence of dilatation of intra and extra-hepatic biliary ducts, it is useful to know if 
obstacles are present in the CBD. These patients should undergo a MRCP to determine the 
conditions of the CBD before cholecystectomy. In these cases, in fact, the extensive use of 
MRCP can be useful for a significant reduction of the number of non-therapeutic ERCP/ES 
and their associated complications. The clinical scenario is, in 20-30% of cases, a severe 
pancreatitis characterized by extensive pancreatic and peripancreatic necrosis, fluid 
collections at risk of infection, possible systemic inflammatory response syndrome (SIRS) 
with impairment of the patient’s clinical conditions which always requires starting 
immediately intensive therapy. Besides, 20% of SAP show an early severity – ESAP - with 
development within 72 hours of multiple organ failure and within 2 weeks of infection of 
the pancreatic and peripancreatic necrotic collections with high mortality (40-60%). Thus, in 
all severe pancreatitis it is necessary a prolonged control of the pancreatic and 
peripancreatic necrotic collections which are exposed to infectious complications. Early 
(within 72 hours) ES has proved to be successful to maintain and to control the evolution of 
the inflammatory process and also safe to prevent close inflammatory-necrotic recurrences, 
which are caused by the persistence of the papillary obstacle and of the biliary reflux in the 
pancreatic duct (Folsch et al, 1997; Heider et al, 2006; Hernandez et al, 2004; Kimura et al, 
2006; Neoptolemos et al, 1988; Sungler et al, 2007 ; Van Geenen et al, 2009). Cholecystectomy 
is definitely indicated, but should be programmed once the patient’s clinical conditions are 
stable. Another clinical manifestation of biliary pancreatitis is the moderate form. Its 
nosological definition is rather difficult and uncertain, placed between the much better 
identifiable mild and severe forms. Among the moderate forms it is significant, to 
therapeutic goals, to identify the moderate/severe forms (Heider et al,2006) which are 
characterized by pancreatic necrosis, not exceeding 30% of the parenchyma at the CT control, 
edema and phlogosis of the retroperitoneal peripancreatic lodge with possible fluid 
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collections. In these forms impairment of the patient’s clinical conditions with multi-organ 
dysfunction is absent. Also, infection of the fluid collections occurs rarely. The resolution of 
symptoms occurs in a relatively short time, 10 days on average; return to normality of serum 
amylase and lipase levels is slower and so is the resolution of the pancreatic and 
peripancreatic phlogosis/necrosis and the fluid collections reabsorption. Also in these cases 
early (within 72 hours) ES is effective to reduce the risk of an often even earlier recurrence of 
pancreatitis. Cholecystectomy can be performed when the patient’s clinical conditions are 
restored, almost always during the same hospitalization. The pathogenesis of acute biliary 
pancreatitis is based on the alteration of transpapillary flow caused by edema and/or 
mechanical obstacle which determines the pancreatic intra-ductal reflux. Thus ES by 
normalizing the biliopancreatic transpapillary flow removes the morphofunctional 
alteration and reduces the risk of pancreatitis recurrences, which present themselves 
sometimes with acute close episodes. Besides, ERCP/ES allow at the same time to clean the 
CBD in case of sludge, microlithiasis or stones. Once the initial pathogenesis has been 
defined, it remains to establish which patients with acute biliary pancreatitis should 
undergo ES. ES is indicated in severe and in moderate/severe pancreatitis, and, of course, in 
acute recurrent pancreatitis, irrespective of the presence of laboratory, clinical and 
instrumental signs of cholestasis or of a lithiasic obstacle in the CBD which, if present, 
constitute further motive for ES. On the contrary, moderate/mild pancreatitis does not 
require endoscopic treatment unless cholestasis is present. In patients with recurrent 
pancreatitis, according to the pathogenetic sequence papillary obstacle / biliopancreatic 
reflux, the necessity to restore the papillary patency with ES is assumed. In our experience 
recurrent pancreatitis is present in 30% of acute biliary pancreatitis treated. Recurrent 
pancreatitis occupies a nosographic place which presents a special interest because it can 
represent the connection between acute pancreatitis and chronic pancreatitis. A relevant 
contribution to the definition of the therapeutic choice and of the possible nosological 
organization which may clarify the possible evolutions of acute pancreatitis (ex: recurrent 
acute pancreatitis evolving to chronification of the phlogistic lesions) may come from the 
careful and extended clinical observation integrated with repeated instrumental 
verifications: US-CT-MRCP. In fact, ever since its onset, we can consider pancreatitis as a 
difficult disease to classify, whose possibilities of evolution can be influenced by numerous 
etiopathogenetic factors and which should be subject to a dynamic follow- up. Acute 
pancreatitis can evolve into the chronic form as the result of recurrences of repeated 
episodes of papillary obstruction secondary to edema and to sclerotic evolution of the 
inflammatory reaction of the sphincter of Oddi. Biliary lithiasis, with passage of stones, 
biliary sludge, microstones or with persistent lithiasic obstacle of the papilla, plays a 
considerable role in the genesis of the sclerosis of the sphincter of Oddi. In this light, ES in 
the treatment of recurrent acute biliary pancreatitis may have a role of prevention against an 
hypothesized papillary fibrotic evolution of the phlogosis with consequent chronification. 
The process that brings to pancreatic fibrotic alterations corresponds clinically to repeated 
episodes of typical abdominal pains and increased levels of serum amylase and lipase which 
are caused by recurrences of acute pancreatitis. The episodes of parenchymal inflammation 
evolve towards the self-limitation of the phlogosis without sequels, as an alternative to the 
evolution towards chronification. The recurrent pancreatitis presents itself with the 
anatomopathological substrate of an acute inflammatory focus during the course of chronic 
pancreatitis. In a general picture, the possible evolutions of the pancreatic inflammations are 
self-limitation, progression with self-digestion and extensive necrosis of the parenchyma 
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and of the surrounding tissues, or an evolution with predominance of fibrosis and 
calcifications which characterize chronic phogosis. Finally, ES plays a double preventive 
role, interrupting the recurrence of acute attacks and the possible chronification of the 
phlogistic process. Recurrent acute biliary pancreatitis has been caused, in patients 
discharged from the hospital without additional treatment, by persistent papillary obstacle 
(small stones, sludge, microlithiasis, cholesterol crystals). Therefore we confirm the 
therapeutic validity of instrumental control (US/MRCP) and the possible treatment 
(ERCP/ES) of papillary or biliary lithiasic obstacle for the prevention of recurrent acute 
biliary pancreatitis. ES plays an important role in the treatment of ABP and a most 
important role in recurrent pancreatitis because of the persistent papillary obstacle. In 
severe, moderate/severe and recurrent pancreatitis, instrumental confirmation of 
papillary obstacle is not necessary because this is persistent. On the contrary, in 
mild/moderate pancreatitis laboratory, US and MRCP confirmation of papillary or CBD 
lithiasic obstacle is useful prior to ERCP/ES because the papillary obstacle is transient. 
Patients with mild/moderate pancreatitis without cholestasis indexes should undergo 
instrumental control with MRCP for lithiasic obstacles in the CBD prior VLC because in a 
very variable range (45-75%) of acute biliary pancreatitis stones are present in the CBD. 
The results of these evaluations show the efficacy of the therapeutic program with 
ERCP/ES in the prevention of recurrent acute biliary pancreatitis with mini-invasive 
approach. The pathogenetic modalities of recurrent pancreatitis are well defined and 
obvious in the forms with biliary aetiology. However there are recurrent pancreatitis also 
among pancreatitis with different aetiology: these are less frequent pancreatitis for which 
a smaller number of observations is available and therefore with a somewhat uncertain 
characterization. 
3. Alcoholic pancreatitis 
The diagnosis of alcoholic pancreatitis is based on the definition of alcohol consumption and 
on the presence of anatomopatological alterations assessed with morphological 
examinations (X-rays, CT, EUS, wirsungraphy): parenchymal anomalies and of the excretory 
ducts with or without calcifications. In the course of alcoholic pancreatitis, recurrent 
episodes of acute pancreatitis can evolve into chronic pancreatitis and the effective and 
determining way of the recurrence of acute attacks can be evidenced (Gorelick, 2003; 
Spanier et al,2008; Whitcomb, 2005). In fact, most observers currently believe that chronic 
pancreatitis which follows prolonged ethanol abuse reflects repeated but subclinical, 
episodes of acute pancreatic injury. These repeated episodes of pancreatic injury with 
necrosis lead to fibrosis which characterizes chronic pancreatitis (Kloppel,1999). There are 
numerous theories since long presented in literature which propose an explanation of the 
lesive action of alcohol on pancreatic parenchyma but none of them is completely acquired. 
Alcohol would cause hypertriglyceridemia, fat acid and ethyl esters formation, that is 
formation of oxygen free radicals, causing pancreatic phlogistic damage. According to 
another hypothesis, alcohol alters the composition of pancreatic secretions with reduction of 
inhibiting enzymes and proteins precipitation forming intraductal plugs. Ductal obstruction 
causes increase in endoluminal pressure and consequent phlogosis with multiple foci of 
pancreatitis. Also the spasm of the sphincter of Oddi has been attributed to the action of 
alcohol. 
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4. Processes obstructing the flow of pancreatic juice, pancreas divisum 
Obstructions of various nature of the main pancreatic excretory duct can cause pancreatitis 
too, in the parenchymal territory proximal to the obstruction. The obstacle can be a ductal 
neoplasia (IPMN) (Fazel et al ,2005) or a papillary alteration (periampullary diverticula, 
duodenal ulcer, duodenal Crohn, post-traumatic stenosis of the duct of Wirsung), or 
pancreas divisum (Arya et al, 2006; Gelrud et al, 2004). Pancreas divisum can cause acute 
pancreatitis for the small-caliber of the minor papilla which represents an obstacle to 
pancreatic flow. The endoscopic control of pressure in the pancreatic duct shows values 
more elevated than in normal patients. This hypothesis is at the basis of the therapeutic 
procedure of sphincterotomy of the pancreatic minor papilla. Therapeutic success reaches 
80% (Bradley & Stephan,1996). The pancreatitis from ductal obstruction can present itself 
with an acute attack, orienting clinically to an acute form involving all the gland, but the 
histological characteristics are attributable to a chronic phlogosis which is limited to the 
portion of gland proximal to the obstruction. Also in this case, the evolution of the anatomo-
pathological lesion is characterized by the sequence phlogosis-proteolisis-necrosis-fibrosis. 
In advanced stages of chronic pancreatitis ductal stenoses and gallstones can be the base of 
acute attacks of pancreatitis. However, recurrent acute attacks are documented also in the 
early stages of alcoholic chronic pancreatitis (Garg et al,2007). In summary, it is not well 
established whether initial chronic pancreatitis is the cause of recurrent acute pancreatitis or 
whether, on the contrary, acute recurrent attacks of pancreatitis evolve into chronic 
pancreatitis. In general, for pancreatitis caused by an obstacle to the flow of pancreatic 
secretions, the treatment consists in the removal of the obstacle. However, the specific 
treatment is deeply diversified according to the nature of the obstacle: ampullary and 
periampullary tumors and intraductal neoplastic stenoses must be removed surgically; 
small pancreatic stones or phlogistic stenosis can be treated with endoscopical procedures. 
5. Hereditary pancreatitis 
In hereditary pancreatitis (Ferec & Maire,2005; Whitcomb, 1999), the intraparenchymal 
activated trypsinogen is not inhibited by the antienzymes which are inactive for genetic 
causes, that is because it is present trypsin rendered genetically resistant to antitrypsin. The 
effect is a series of recurrent episodes of pancreatitis which induce parenchymal chronic 
alterations with fibrosis, calcifications and sclerosis. 
6. Autoimmunitary pancreatitis 
The autoimmunitary phlogistic process in pancreatitis is characterized by a sclerotic effect 
(Hamano et al, 2001) with conspicuous lymphoplasmacellular infiltrates. In these cases, 
phlogosis is delimited sometimes in a mass which, if in the pancreatic head, can  
cause biliopancreatic ductal obstruction, simulating a neoplastic lesion (autoimmune 
lymphoplasmacellular pancreatitis or eosinophilic pancreatitis).  
7. Metabolic pancreatitis 
Possible recurrences of acute attacks with phlogosis which evolve into fibrosis and  
chronic sclerosis occur for hypercalcaemia and hyperlipidemia. Hypercalcaemia (in 
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hyperparathyroidism) causes pancreatitis for the increased activation of proteolytic 
digestive enzymes. Hyperlipidemia causes pancreatitis because chylomicrons and free fat 
acids in excess interfere with pancreatic microcirculation. The circulatory alteration is the 
base of ductal obstructions of fibrous origin (obstructive mechanism).  
8. Pancreatitis in celiac disease 
Celiac disease (CD) is an immune mediated enteropathy caused by permanent insensivity to 
gluten in genetically susceptible individuals. Some recent reports have shown an association 
between acute pancreatitis and CD. A recent epidemiological study has shown that patients 
with CD have a higher risk than the general population for development of acute 
pancreatitis with epigastric pain and biochemical and radiographic confirmation 
(Ludvigsson et al, 2007). There are in the literature many pathogenetic mechanisms to 
explain the development of pancreatitis in patients with CD. T helper cell class 1 (TH1) 
cytokine up-regulation in CD may be predisposing factor for acute pancreatitis (Ludvigsson 
et al,2007). Another hyphotesis suggests that malnutrition can cause pancreatitis 
(Ludvigsson et al, 2007). However there is no evidence to show improvement of pancreatitis 
after correction for malnutrition. The mechanism for recurrent pancreatitis in CD may be 
papillary stenosis resulting from localized duodenal inflammation (Patel et al, 1999; Sood et 
al, 2007). The ES is the possible treatment. On the other hand it is also postulated that the 
improvement of recurrent episody of pancreatitis is a result of gluten restriction (Patel et al, 
1999)). 
9. Idiopathic pancreatitis 
Idiopathic pancreatitis, that is with undefined etiology, represent approximately 20% of all 
cases. Among them, however, an important number can be ascribed to biliary forms with 
microstones or biliary sand of which there is no sure confirmation, that is they are caused by 
dysfunction of the sphincter of Oddi , generally of difficult demonstration. 
10. Sphincter of Oddi dysfunction  
Sphincter of Oddi dysfunction (SOD) can be due to stenosis or dyskinesia. Stenosis is a 
structural alteration due to inflammation and consequent stenosis (ex. passage of stones). 
Dyskinesia, instead, is a functional disorder with hypertonia. Stenosis or dyskinesia can 
involve the biliary sphincter, the pancreatic sphincter or the common sphincter. The 
clinical pictures may be slightly different if the alteration involves the biliary sphincter 
(pain of biliary type, biliary enzymes increase) or the pancreatic sphincter (pain of 
pancreatic type, recurrent attacks of pancreatitis). In summary, the phlogistic process is 
due to the obstruction and to the increased pressure in the pancreatic excretory system. 
The therapeutic indication in SOD is endoscopic sphincterotomy. Criteria for this 
diagnosis are represented by dilatation (> 8 milimeter) of the common bile duct, delayed 
emptying (more than 45 ') after ERCP, increased levels of alkaline phosphatase and 
gamma-GT during the episodes of pain. Certainty of diagnosis is based on finding, on 
manometry during ERCP, elevated pressure in the sphincter of Oddi (> 40 mmHG). Tc-
99m iminodiacetic acid (IDA) cholescintigraphy is helpful for the diagnosis. It is moreover 
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possible that the dysfunction of the sphincter of Oddi be present also in patients who did 
not undergo cholecistectomy. Three levels of diagnostic certainty are distinguished. In 
type 1 SOD the three clinical criteria above mentioned are present and manometry of the 
sphincter is superfluous. In type 2 SOD two clinical criteria are present or or only one but 
this one must not be pain. In this case manometry of the sphincter of Oddi is necessary 
and is pathological in half of the cases. Lastly in type 3 SOD only pain is present in the 
right hypochondriac region. Manometry of the sphincter is necessary. Moreover, in these 
cases of uncertain assessment the answer to the sphincterotomy is not sure (Vassiliou & 
Laycock,2008). In fact endoscopic sphincterotomy, in particular of pancreatic sphincter, 
can prevent the recurrence of dysfunction of the sphincter of Oddi in 60% of cases (Elta, 
2008). 
In conclusion, the sequence of physiopathologic events which underlies pancreatic 
parenchymal phlogosis has overlapping characteristics in acute and chronic pancreatitis. 
The inflammatory process, caused by ductal obstruction or for cleansing, by the biliary 
reflux, of the mucosa of the main pancreatic duct, is determined by the action, in the 
acinar cells of pancreas, of the same proteolytic enzymes produced there. Chronic 
pancreatitis is caused by repeated episodes of subclinic acute pancreatitis with 
parenchymal necrosis evolving into fibrosis. Therefore, the hypotheses to consider are the 
activation of proteolytic enzymes and of trypsinogen in the same acinar cells or the 
reduced inhibitory action of antienzymes that is, in the end, the activated 
intraparenchymal diffusion of the pancreatic secretions activated in the lumen of the 
excretory duct for the alteration of its mucous barrier. Recurrent, also subclinical, episodes 
of acute pancreatitis with phlogosis and necrosis evolve into the fibrosis and the sclerosis 
of chronic pancreatitis. It must still be explained how the obstruction of the main 
pancreatic duct or of smaller ducts can induce the intracellular activation of proteolytic 
enzymes. Steer (Steer,1998) has advanced the hypothesis of the colocalization. According 
to this hypothesis, based on experimental data, enzymes like trypsinogen and lyisosomial 
hydrolase as catepsin B are localized together in the cytoplasmic vacuoli. In these 
conditions catepsin B can activate trypsinogen into trypsin which with its proteolytic 
action causes self-digestion and intraparenchymal phlogosis. The intensity of the 
inflammatory response can regulate the severity of pancreatitis. 
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